Advertisement

Topics

Kineta CEO Unveils Its Immuno-oncology Program at the BIO Investor Forum

04:48 EDT 19 Oct 2016 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
SEATTLE, Oct. 19, 2016 /PRNewswire/ -- Kineta, Inc., a biotechnology company focused on the translational development of novel antiviral and immune modulating therapies announced that its CEO, Dr. Shawn Iadonato, joined a panel of leaders from other b...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Kineta CEO Unveils Its Immuno-oncology Program at the BIO Investor Forum"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...